Moreover, plasma apelin levels were significantly reduced in patients with PSC (160.2 ± 28.1 pg/mL) compared to controls (287.2 ± 37.4 pg/mL) (p = 0.009; Figure 1D). This evidence concerns the gene APLN and pancreatic serous cystadenoma.